Search alternatives:
mg decrease » _ decrease (Expand Search), nn decrease (Expand Search), we decrease (Expand Search)
ns decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
mg decrease » _ decrease (Expand Search), nn decrease (Expand Search), we decrease (Expand Search)
ns decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
661
-
662
-
663
GBE did not modify cell morphology but decreased reactive oxygen species (ROS) levels.
Published 2010“…<b>C</b>) Mitochondria-associated ROS levels measured after incubation with DHR (DHR fluorescence units/1×10<sup>5</sup> cells). ROS levels showed a trend to be increased in APP cells compared to control cells (<sup>(</sup>*<sup>)</sup>p = 0.082, unpaired student's t-test, n = 11, values represent the means ± S.E.). …”
-
664
-
665
-
666
-
667
Lipolytic treatment decreased cellular neutral lipids and increased extracellular fatty acids and glycerol.
Published 2014“…Cellular neutral lipids (corresponding to µmol of fatty acids in cellular neutral lipids) were expressed per mg of total cell protein (A). A significant decrease of cellular lipid contents was noted throughout the lipolytic process for the conditions with PCB-28 (<i>p</i> = 0.005) and the cocktail of PCBs (<i>p</i> = 0.029). …”
-
668
-
669
-
670
GCase activity is significantly decreased in the brain and liver of the homozygous <i>GBA1</i> D409V KI mouse model at 4, 8, and 12 months of age.
Published 2021“…In whole brain homogenate (A,C) and liver homogenate (B,D), GCase activity is significantly decreased in the <i>GBA1</i> D409V KI homozygous (HOM) mice as compared to C57Bl/6 wild type (WT) mice (n = 7/group). …”
-
671
Cost-effectiveness and budget impact of immediate antiretroviral therapy initiation for treatment of HIV infection in Côte d’Ivoire: A model-based analysis
Published 2019“…Outcomes from the model included life expectancy, 10-year medical resource use, incremental cost-effectiveness ratios (ICERs) in $/year of life saved (YLS), and 5-year budget impact. We simulated people with HIV (PWH) in care (mean CD4: 259/<i>μ</i>L, SD 198/<i>μ</i>L) and transmitted cases. …”
-
672
TIP47 is involved in HCV RNA replication <i>via</i> interaction with NS5A.
Published 2013“…<p>A) Schematic representation of the HCV Replicon (genotype 1b) and Luc-JFH1 (genotype 2a), with mutations at position 9 and 12 in the NS5A N-terminus. B) Crystal violet-stained Huh7.5 cells transfected with wild-type or mutant HCV replicon RNA (genotype 1b). 24 h post-transfection, G418 was added to the medium (1 mg/ml). …”
-
673
Spatial representation of mean annual soil loss increase/decrease derived with the different modeling centers (rows) and time steps (columns) with the SSP5-8.5.
Published 2023“…<p>Spatial representation of mean annual soil loss increase/decrease derived with the different modeling centers (rows) and time steps (columns) with the SSP5-8.5.…”
-
674
Discovery of New Inhibitors of Hepatitis C Virus NS3/4A Protease and Its D168A Mutant
Published 2019“…Hepatitis C virus (HCV) is a human pathogen with high morbidity. The HCV NS3/4A protease is essential for viral replication and is one of the top three drug targets. …”
-
675
-
676
AQP2 and p-AQP2 abundance.
Published 2015“…Both antibodies reveal specific 29 kDa and 35–50 kDa bands. Data are presented in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0116501#pone.0116501.t004" target="_blank">Table 4</a>. …”
-
677
AQP1 abundance.
Published 2015“…Immunoblot was reacted with anti-AQP1 antibody and reveals 29 kDa and 35–50 kDa AQP1-bands (<i>A-E</i>). Data are presented in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0116501#pone.0116501.t009" target="_blank">Table 9</a>. …”
-
678
-
679
-
680
Mean scores and 95% CIs according to SARS-CoV-2 infection status and work-related determinants.
Published 2025Subjects: